Marie-Line Garron and her team provide groundbreaking structural insights into the BCAR3 and HEF1 (NEDD9/Cas-L) complex, revealing its significant role in anti-estrogen resistance and integrin signaling in breast cancer [44]. This evidence concerns the gene NEDD9 and breast carcinoma.